← FDA Drug Approvals (Drugs@FDA)

ACETAMINOPHEN AND IBUPROFEN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GRANULES · Approved 2023-07-13

Drug application

FDA Application #

ANDA216592

Application type

Abbreviated New Drug Application (Generic)

Brand name

ACETAMINOPHEN AND IBUPROFEN

Generic name

ACETAMINOPHEN, IBUPROFEN

Active ingredients

ACETAMINOPHEN; IBUPROFEN

Dosage form

TABLET

Route

ORAL

Marketing status

Over-the-counter

Sponsor

GRANULES

Manufacturer

Kai Squared

First approval

2023-07-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown